Thursday, November 20, 2008 - 6:17AM EST

Drug Therapy

8. Growth hormone therapy in congestive heart failure due to left ventricular systolic dysfunction: a meta-analysis.

Author
Tritos NA; Danias PG;
Institution
Department of Endocrinology, Lahey Clinic Medical Center, Burlington, Massachusetts 01805, USA. Nicholas.A.Tritos@Lahey.org
Journal
Endocr Pract. 2008 Jan-Feb;14(1):40-9.
Abstract URL
Click here to view abstract

9. Use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with congestive heart failure: an observational study of treatment rates and clinical outcome.

Author
Gotsman I; Rubonivich S; Azaz-Livshits T;
Institution
Heart Institute, Hadassah University Hospital and Hebrew University-Hadassah Medical School, Jerusalem, Israel. igotsman@bezeqint.net
Journal
Isr Med Assoc J. 2008 Mar;10(3):214-8.
Abstract URL
Click here to view abstract

10. Effect of different angiotensin-converting-enzyme inhibitors on mortality among elderly patients with congestive heart failure.

Author
Pilote L; Abrahamowicz M; Eisenberg M; Humphries K; Behlouli H; Tu JV;
Institution
Division of Internal Medicine and Epidemiology, Montreal General Hospital, Montreal, Que.
Journal
CMAJ. 2008 May 6;178(10):1303-11.
Abstract URL
Click here to view abstract

11. Use of a high thoracic epidural analgesia for treatment of end-stage congestive heart failure secondary to coronary artery disease: effect of HTEA on CHF.

Author
Shuang W; Shiying F; Fengqi L; Renhai Q; Lanfeng W; Zhuqin L; Xu W;
Institution
Journal
Int J Cardiol. 2008 Apr 10;125(2):283-5. Epub 2007 Dec 3.
Abstract URL
Click here to view abstract
Pages: 1 2